-
Je něco špatně v tomto záznamu ?
FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention
L. Zlatohlavek, M. Vrablik, E. Motykova, R. Ceska, L. Vasickova, D. Dlouha, JA. Hubacek,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10589
MZ0
CEP - Centrální evidence projektů
- MeSH
- dítě MeSH
- energetický příjem MeSH
- frekvence genu MeSH
- genetická epistáze MeSH
- genetické asociační studie MeSH
- index tělesné hmotnosti MeSH
- lidé MeSH
- mladiství MeSH
- nadváha genetika terapie MeSH
- obezita genetika terapie MeSH
- polymorfismus genetický MeSH
- programy na snížení hmotnosti MeSH
- proteiny genetika MeSH
- receptor melanokortinový typ 4 genetika MeSH
- redukční dieta MeSH
- sekvenční analýza DNA MeSH
- terapie cvičením MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: This study aimed to determine whether there is a relationship between common FTO (rs17817449) and MC4R (rs17782313) gene variants and body mass reduction or weight loss after a one-month lifestyle intervention in overweight/obese children. DESIGN AND METHODS: We genotyped 357 unrelated non-diabetic Czech children (age 13.7 ± 4.9 years, average BMI at baseline 30.8 ± 4.6 kg/m(2)). Biochemical and anthropometrical measurements were performed before and after 4 weeks of lifestyle interventions (comprising a reduction in energy intake to the age-matched optimum and a supervised exercise program consisting of 5 exercise units per day, 50 min each). RESULTS: The mean weight loss achieved was 6.2 ± 2.1 kg (P<0.001). Significant associations were found between a BMI decrease and the FTO and MC4R variants. Carriers of the FTO GG genotype and/or MC4R CC genotype lost significantly more body weight compared to noncarriers (P<0.0009 for BMI and P<0.002 for body weight). These differences remained significant following adjustment for sex, age and baseline values (P=0.004 for BMI and P=0.01 for body weight). CONCLUSIONS: FTO and MC4R gene variants modify the impact of an intensive lifestyle intervention on BMI decrease in overweight/obese children. Carriers of the FTO GG genotype and MC4R CC genotype benefit significantly more from the lifestyle intervention.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031795
- 003
- CZ-PrNML
- 005
- 20170411120537.0
- 007
- ta
- 008
- 131002s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clinbiochem.2012.11.017 $2 doi
- 035 __
- $a (PubMed)23201545
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zlatohlavek, L $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. l.zlato@tiscali.cz
- 245 10
- $a FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention / $c L. Zlatohlavek, M. Vrablik, E. Motykova, R. Ceska, L. Vasickova, D. Dlouha, JA. Hubacek,
- 520 9_
- $a OBJECTIVES: This study aimed to determine whether there is a relationship between common FTO (rs17817449) and MC4R (rs17782313) gene variants and body mass reduction or weight loss after a one-month lifestyle intervention in overweight/obese children. DESIGN AND METHODS: We genotyped 357 unrelated non-diabetic Czech children (age 13.7 ± 4.9 years, average BMI at baseline 30.8 ± 4.6 kg/m(2)). Biochemical and anthropometrical measurements were performed before and after 4 weeks of lifestyle interventions (comprising a reduction in energy intake to the age-matched optimum and a supervised exercise program consisting of 5 exercise units per day, 50 min each). RESULTS: The mean weight loss achieved was 6.2 ± 2.1 kg (P<0.001). Significant associations were found between a BMI decrease and the FTO and MC4R variants. Carriers of the FTO GG genotype and/or MC4R CC genotype lost significantly more body weight compared to noncarriers (P<0.0009 for BMI and P<0.002 for body weight). These differences remained significant following adjustment for sex, age and baseline values (P=0.004 for BMI and P=0.01 for body weight). CONCLUSIONS: FTO and MC4R gene variants modify the impact of an intensive lifestyle intervention on BMI decrease in overweight/obese children. Carriers of the FTO GG genotype and MC4R CC genotype benefit significantly more from the lifestyle intervention.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a redukční dieta $7 D004038
- 650 _2
- $a energetický příjem $7 D002149
- 650 _2
- $a genetická epistáze $7 D004843
- 650 _2
- $a terapie cvičením $7 D005081
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a obezita $x genetika $x terapie $7 D009765
- 650 _2
- $a nadváha $x genetika $x terapie $7 D050177
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a proteiny $x genetika $7 D011506
- 650 _2
- $a receptor melanokortinový typ 4 $x genetika $7 D044105
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 650 _2
- $a programy na snížení hmotnosti $7 D061217
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vrablik, M $u -
- 700 1_
- $a Tůmová, Eva $u - $7 xx0210915
- 700 1_
- $a Ceska, R $u -
- 700 1_
- $a Vasickova, L $u -
- 700 1_
- $a Dlouha, D $u -
- 700 1_
- $a Hubacek, J A $u -
- 773 0_
- $w MED00001119 $t Clinical biochemistry $x 1873-2933 $g Roč. 46, č. 4-5 (2013), s. 313-316
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23201545 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20170411120836 $b ABA008
- 999 __
- $a ok $b bmc $g 995882 $s 830240
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 46 $c 4-5 $d 313-316 $i 1873-2933 $m Clinical biochemistry $n Clin Biochem $x MED00001119
- GRA __
- $a NS10589 $p MZ0
- LZP __
- $a Pubmed-20131002